by Ket Patel | Nov 24, 2011 | All Articles For Psychiatry, Sleep Disorders
A low-dose sublingual formulation of zolpidem tartrate is the first agent to be approved to treat insomnia characterized by middle-of-the-night waking followed by difficulty returning to sleep, the Food and Drug Administration announced Nov. 23. Zolpidem tartrate was...
by Ket Patel | Nov 20, 2011 | All Articles For Neurology, Movement Disorders
Major Finding: Significantly more individuals with hyposmia had DAT levels of 65% or lower, compared with normosmic individuals (11% vs. 1%). Data Source: Preliminary findings among 303 participants in PARS. Disclosures: The study is sponsored by the U.S. Department...
by Ket Patel | Nov 15, 2011 | All Articles For Neurology, Epilepsy
Almost half the patients who undergo surgery for epilepsy remain seizure free 10 years postop, but further improvements in presurgical assessment and surgical treatment of people with chronic epilepsy are needed to improve success rates, according to findings from a...
by Ket Patel | Nov 14, 2011 | All Articles For Neurology, Alzheimer's Disease
Major Finding: Monthly infusion with 200 mg gantenerumab, a monoclonal antibody to amyloid-beta, resulted in an average 15% decline in the amount of brain amyloid-beta in patients with mild to moderate Alzheimer’s disease. Data Source: Randomized trial of 16...
by Ket Patel | Nov 14, 2011 | All Articles For Psychiatry, Sleep Disorders
A series of “on-off” switches regulates sleep, clarifying many of the mechanisms underlying narcolepsy, cataplexy, and REM sleep behavior disorder, according to Dr. Clifford B. Saper. The states of sleep and wakefulness and rapid eye movement and non-REM sleep can...
